Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.

Klippel S, Jakubikova J, Delmore J, Ooi M, McMillin D, Kastritis E, Laubach J, Richardson PG, Anderson KC, Mitsiades CS.

Br J Haematol. 2012 Nov;159(3):340-51. doi: 10.1111/j.1365-2141.2012.09253.x. Epub 2012 Sep 13.

2.

Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis.

Ofer K, Gold D, Flescher E.

Int J Parasitol. 2008 Jul;38(8-9):959-68. doi: 10.1016/j.ijpara.2007.12.008. Epub 2008 Jan 26.

PMID:
18294640
3.

Jasmonates--a new family of anti-cancer agents.

Flescher E.

Anticancer Drugs. 2005 Oct;16(9):911-6. Review.

PMID:
16162967
4.

Methyl jasmonate: a plant stress hormone as an anti-cancer drug.

Cohen S, Flescher E.

Phytochemistry. 2009 Sep;70(13-14):1600-9. doi: 10.1016/j.phytochem.2009.06.007. Epub 2009 Aug 5. Review.

PMID:
19660769
5.

Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.

Wang Y, Xiang W, Wang M, Huang T, Xiao X, Wang L, Tao D, Dong L, Zeng F, Jiang G.

Br J Pharmacol. 2014 Feb;171(3):618-35. doi: 10.1111/bph.12501.

6.

The anti-cancer activities of jasmonates.

Raviv Z, Cohen S, Reischer-Pelech D.

Cancer Chemother Pharmacol. 2013 Feb;71(2):275-85. doi: 10.1007/s00280-012-2039-z. Epub 2012 Nov 30. Review.

PMID:
23196641
7.

Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.

Yeruva L, Hall C, Elegbede JA, Carper SW.

Anticancer Drugs. 2010 Jan;21(1):1-9. doi: 10.1097/CAD.0b013e32832a68ad.

8.
9.

Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.

Raviv Z, Zilberberg A, Cohen S, Reischer-Pelech D, Horrix C, Berger MR, Rosin-Arbesfeld R, Flescher E.

Br J Pharmacol. 2011 Nov;164(5):1433-44. doi: 10.1111/j.1476-5381.2011.01419.x.

10.

Methyl jasmonate binds to and detaches mitochondria-bound hexokinase.

Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T, Bronner V, Notcovich A, Shoshan-Barmatz V, Flescher E.

Oncogene. 2008 Aug 7;27(34):4636-43. doi: 10.1038/onc.2008.108. Epub 2008 Apr 14.

PMID:
18408762
11.

Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice.

Li J, Chen K, Wang F, Dai W, Li S, Feng J, Wu L, Liu T, Xu S, Xia Y, Lu J, Zhou Y, Xu L, Guo C.

Oncotarget. 2017 Jul 11;8(28):45965-45980. doi: 10.18632/oncotarget.17469.

12.

Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.

Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E.

Cancer Res. 2005 Mar 1;65(5):1984-93.

13.

Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.

Goldin N, Heyfets A, Reischer D, Flescher E.

J Bioenerg Biomembr. 2007 Feb;39(1):51-7. Review.

PMID:
17549642
14.

Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells.

Yeruva L, Elegbede JA, Carper SW.

Anticancer Drugs. 2008 Sep;19(8):766-76. doi: 10.1097/CAD.0b013e32830b5894.

15.

Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.

Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, Flescher E.

Br J Pharmacol. 2005 Nov;146(6):800-8.

16.

Combined chemotherapy or biotherapy with jasmonates: targeting energy metabolism for cancer treatment.

Elia U, Flescher E.

Curr Pharm Biotechnol. 2013;14(3):331-41. Review.

PMID:
22201595
17.

Antidepressant activity of methyl jasmonate, a plant stress hormone in mice.

Umukoro S, Akinyinka AO, Aladeokin AC.

Pharmacol Biochem Behav. 2011 Mar;98(1):8-11. doi: 10.1016/j.pbb.2010.12.001. Epub 2010 Dec 8.

PMID:
21145342
18.
19.

Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice.

Lu CC, Yang JS, Chiang JH, Hour MJ, Lin KL, Lin JJ, Huang WW, Tsuzuki M, Lee TH, Chung JG.

PLoS One. 2012;7(5):e36831. doi: 10.1371/journal.pone.0036831. Epub 2012 May 25.

20.

Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.

Milrot E, Jackman A, Flescher E, Gonen P, Kelson I, Keisari Y, Sherman L.

Invest New Drugs. 2013 Apr;31(2):333-44. doi: 10.1007/s10637-012-9870-2. Epub 2012 Sep 6.

PMID:
22956285

Supplemental Content

Support Center